Warren Buffett is a renowned American billionaire and one of the most successful investors in the world. He is often reffered to as ‘the Oracle of Omaha‘. He was the favourite student of Benjamin Graham, the father of value investing. In plain terms, Graham’s method involves spotting good, undervalued companies, buying them, and holding them forever.

What do I mean by ‘good‘ companies? Well, most importantly, they have to be profitable. This doesn’t just mean having high net profit margins. It also means a company should have a good track record of rising profits. Of course, this doesn’t guarantee the firm’s profitability will keep rising in the future. But at least it makes investing in such a company somewhat safer. Of course, dividend-paying companies have a big advantage over their peers that don’t pay dividends.

Then, a great business should also have a sound financial … Read more

Supreme Court Justice Ruth Bader Ginsburg, a diminutive yet towering women’s rights champion who became the court’s second female justice, died Friday at her home in Washington. She was 87.

Ginsburg died of complications from metastatic pancreatic cancer, the court said.

Ginsburg announced in July that she was undergoing chemotherapy treatment for lesions on her liver, the latest of her several battles with cancer.

Ginsburg spent her final years on the bench as the unquestioned leader of the court’s liberal wing and became something of a rock star to her admirers. Young women especially seemed to embrace the court’s Jewish grandmother, affectionately calling her the Notorious RBG, for her defense of the rights of women and minorities, and the strength and resilience she displayed in the face of personal loss and health crises.

Those health issues included five bouts with cancer beginning in 1999, falls that resulted in broken ribs, … Read more

Snowflake (NYSE: SNOW) shares were listed on the New York Stock Exchange this week. On its first day of trading, the share price popped higher to more than double. The cloud data warehousing firm had the largest software initial public offering (IPO) on record, valuing it at around $70bn – more than five times the private market valuation it reached in February.

Snowflake shares were priced at $120, after being revised higher twice this month. On the first day of trading, the share price climbed to over $300, and finished the day up 112% at $255.

Early investors of Snowflake shares include Salesforce and Berkshire Hathaway. The investment by the conglomerate run by Warren Buffett is interesting. Buffett rarely gets interested in technology startups that are not yet profitable, and tends to opt for more mature companies.

Snowflake’s IPO comes at a similar time to several technology IPOs. It … Read more

In the global sprint to find a COVID-19 vaccine, we’ve seen the world embrace approaches that would have previously been considered unthinkable, from spending billions on untested technologies to compressing clinical trials from years to months. 

These bold steps may be exactly what the world needs to find a vaccine even one day sooner. But unless we bring the same kind of urgency, inventiveness, and investment to vaccine distribution as we have to vaccine development, our attempts to end the COVID-19 pandemic will fail.

Why does delivering the one thing everyone in the world needs merit such an audacious approach? Because vaccines are delicate things; they require near-perfection in our ability to deliver them. 

The COVID-19 vaccine, like most vaccines, will need to be kept cold, fixed within a precise temperature range from the moment it leaves the manufacturer to the moment it’s administered. 

This is hard even in rich … Read more

The demand for pharmaceutical companies’ stocks has surged dramatically. AstraZeneca (LSE:AZN) shares have been no exception. Investor enthusiasm was fuelled by hopes of a new Covid-19 vaccine. But isn’t the AstraZeneca share price already too high? 

Why did the AstraZeneca share price rally?

On Monday, the pharma giant resumed phase 3 vaccine trials. As we all know, the company’s stock has been surging in recent months. That’s because people expect AstraZeneca to develop a Covid-19 vaccine. But is the future so bright for AstraZeneca and its vaccine?

Quite recently the FDA said AstraZeneca’s coronavirus vaccine trial in the US is still pending. That’s because the FDA is unsure if there is a big safety issue or not. So, many questions remain. Phase 3 vaccine trials don’t mean the vaccine will be available tomorrow. What’s more, the FDA’s investigation also suggests there are still many regulatory hurdles. That’s why the AstraZeneca … Read more